Effect of Craniosacral Therapy on Multiple Sclerosis Symptoms
Investigation of the Effectiveness of Craniosacral Therapy in Patients With Multiple Sclerosis: A Randomized Controlled, Single-Blind Study
This study tests if adding craniosacral therapy to regular physiotherapy can help adults with Multiple Sclerosis feel better and manage their symptoms.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 32 (estimated) |
| Ages | 18 Years to 65 Years |
| Sex | All |
| Sponsor | Ankara Yildirim Beyazıt University Academic / other |
| Locations | 1 site (Ankara) |
| Trial ID | NCT06292312 on ClinicalTrials.gov |
What this trial studies
This investigation explores the effectiveness of craniosacral therapy (CST) as a complementary treatment for patients with Multiple Sclerosis (MS). The study aims to assess how CST, a manual therapy that manipulates the craniosacral system, can influence various neurological symptoms associated with MS. Participants will receive CST in addition to conventional physiotherapy, with the goal of improving their overall quality of life and symptom management. The study will include adults aged 18 to 65 with a confirmed diagnosis of MS and specific eligibility criteria.
Who should consider this trial
Good fit: Ideal candidates for this study are adults aged 18 to 65 with a definitive diagnosis of Multiple Sclerosis and an EDSS score between 1-5.5.
Not a fit: Patients with other neurological diseases, recent MS attacks, or severe comorbid conditions may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could provide patients with a novel, non-pharmacological option to alleviate symptoms of Multiple Sclerosis.
How similar studies have performed: While craniosacral therapy has shown promise in treating various neurological conditions, this specific application for Multiple Sclerosis is relatively novel and has not been extensively tested.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * 18 to 65 years old * Definitive diagnosis of MS by a neurologist * EDSS score between 1-5.5 * Not receiving active physical therapy services * Volunteering. Exclusion Criteria: * Having a neurological disease other than MS * Attacks in the last three months * Corticosteraoid use * History of surgery on the spine * Central and peripheral nervous system disease * Pregnancy * Oncological diseases * Severe comorbid somatic and psychiatric disorders * Receiving invasive/manipulative treatment.
Where this trial is running
Ankara
- Ankara Yıldırım Beyazıt University — Ankara, Turkey (Türkiye) (Recruiting)
Study contacts
- Principal investigator: Hilal Aslan, MSc — Ankara Yildirim Beyazıt University
- Study coordinator: Hilal Aslan, MSc
- Email: hilalaslan@aybu.edu.tr
- Phone: 05372565397
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.